Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia · Delayed Price · Currency is AUD 0.0700
-0.0010 (-1.41%)
Jul 17, 2025, 4:10 PM AEST
ASX:LDX Market Cap
ASX:LDX has a market cap or net worth of 52.40 million as of July 17, 2025. Its market cap has increased by 262.88% in one year.
Market Cap
52.40M
Enterprise Value
56.07M
Revenue
23.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since July 5, 2021, ASX:LDX's market cap has decreased from 196.70M to 52.40M, a decrease of -73.36%. That is a compound annual growth rate of -27.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2025 | 53.15M | 102.86% |
| Dec 31, 2024 | 26.20M | -25.44% |
| Dec 29, 2023 | 35.13M | 248.53% |
| Dec 30, 2022 | 10.08M | -93.27% |
| Dec 31, 2021 | 149.80M | -23.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 116.99B |
| Pro Medicus | 33.11B |
| Cochlear | 19.70B |
| Sonic Healthcare | 13.47B |
| Ramsay Health Care | 8.77B |
| Telix Pharmaceuticals | 7.94B |
| Ansell | 4.35B |
| Regis Healthcare | 2.20B |